| Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child JE Haddow, GE Palomaki, WC Allan, JR Williams, GJ Knight, J Gagnon, ... New England Journal of Medicine 341 (8), 549-555, 1999 | 3533 | 1999 |
| Maternal serum screening for Down's syndrome in early pregnancy. NJ Wald, HS Cuckle, JW Densem, K Nanchahal, P Royston, T Chard, ... British medical journal 297 (6653), 883-887, 1988 | 1352 | 1988 |
| Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. WY Craig, GE Palomaki, JE Haddow British medical journal 298 (6676), 784-788, 1989 | 1259 | 1989 |
| DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study GE Palomaki, EM Kloza, GM Lambert-Messerlian, JE Haddow, ... Genetics in medicine 13 (11), 913-920, 2011 | 1222 | 2011 |
| Maternal thyroid deficiency and pregnancy complications: implications for population screening WC Allan, JE Haddow, GE Palomaki, JR Williams, ML Mitchell, ... Journal of medical screening 7 (3), 127-130, 2000 | 978 | 2000 |
| DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study GE Palomaki, C Deciu, EM Kloza, GM Lambert-Messerlian, JE Haddow, ... Genetics in medicine 14 (3), 296-305, 2012 | 770 | 2012 |
| The evaluation of genomic applications in practice and prevention (EGAPP) initiative: methods of the EGAPP working group SM Teutsch, LA Bradley, GE Palomaki, JE Haddow, M Piper, N Calonge, ... Genetics in medicine 11 (1), 3-14, 2009 | 759 | 2009 |
| Association between exposure to environmental tobacco smoke and exacerbations of asthma in children BA Chilmonczyk, LM Salmun, KN Megathlin, LM Neveux, GE Palomaki, ... New England journal of medicine 328 (23), 1665-1669, 1993 | 728 | 1993 |
| Prenatal screening for Down's syndrome with use of maternal serum markers JE Haddow, GE Palomaki, GJ Knight, J Williams, A Pulkkinen, JA Canick, ... New England journal of medicine 327 (9), 588-593, 1992 | 674 | 1992 |
| Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel MS Watson, GR Cutting, RJ Desnick, DA Driscoll, K Klinger, M Mennuti, ... Genetics in medicine 6 (5), 387-391, 2004 | 533 | 2004 |
| EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome GE Palomaki, MR McClain, S Melillo, HL Hampel, SN Thibodeau Genetics in Medicine 11 (1), 42-65, 2009 | 532 | 2009 |
| The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies JA Canick, GE Palomaki, EM Kloza, GM Lambert‐Messerlian, JE Haddow Prenatal diagnosis 33 (7), 667-674, 2013 | 442 | 2013 |
| Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis SA Devaney, GE Palomaki, JA Scott, DW Bianchi Jama 306 (6), 627-636, 2011 | 407 | 2011 |
| Screening of maternal serum for fetal Down's syndrome in the first trimester JE Haddow, GE Palomaki, GJ Knight, J Williams, WA Miller, A Johnson New England Journal of Medicine 338 (14), 955-962, 1998 | 350 | 1998 |
| ACCE: a model process for evaluating data on emerging genetic tests JE Haddow, GE Palomaki, M Khoury Human genome epidemiology: A scientific foundation for using genetic …, 2003 | 322 | 2003 |
| The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer M Mvundura, SD Grosse, H Hampel, GE Palomaki Genetics in Medicine 12 (2), 93-104, 2010 | 321 | 2010 |
| Reference distributions for the negative acute‐phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort RF Ritchie, GE Palomaki, LM Neveux, O Navolotskaia, TB Ledue, ... Journal of clinical laboratory analysis 13 (6), 273-279, 1999 | 316 | 1999 |
| Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening JE Haddow, GE Palomaki, GJ Knight, GC Cunningham, LS Lustig, ... New England Journal of Medicine 330 (16), 1114-1118, 1994 | 291 | 1994 |
| Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical … AR MacRae, PA Kavsak, V Lustig, R Bhargava, R Vandersluis, ... Clinical chemistry 52 (5), 812-818, 2006 | 286 | 2006 |
| Lipoprotein (a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies WY Craig, LM Neveux, GE Palomaki, MM Cleveland, JE Haddow Clinical Chemistry 44 (11), 2301-2306, 1998 | 271 | 1998 |
Nicholas WaldProfessor of Environmental and Preventive MedicineE-mail megerősítve itt: qmul.ac.uk
